The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | Sell(S) | 234 | $286.19 | $67K |
| Jul 2, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Sell(S) | 92 | $286.19 | $26K |
| Jul 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | Option exercise(M) | 327 | — | $0 |
| Jul 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | Tax withholding(F) | 93 | $283.88 | $26K |
| Jul 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | Option exercise(M) | 327 | — | — |
| Jul 1, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Option exercise(M) | 256 | — | $0 |
| Jul 1, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Tax withholding(F) | 73 | $283.88 | $21K |
| Jul 1, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Option exercise(M) | 256 | — | — |
| Jun 8, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Sell(S) | 762 | $263.89 | $201K |
| Mar 27, 2026 | Meltzer Jonathan C | EVP, Operations | Sell(S) | 839 | $267.05 | $224K |
| Mar 27, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Sell(S) | 2K | $267.05 | $436K |
| Mar 26, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Tax withholding(F) | 481 | $268.38 | $129K |
| Mar 26, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Grant(A) | 1K | — | $0 |
| Mar 26, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Grant(A) | 2K | — | $0 |
| Mar 26, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Tax withholding(F) | 451 | $268.38 | $121K |
| Mar 26, 2026 | Meltzer Jonathan C | EVP, Operations | Grant(A) | 2K | — | $0 |
| Mar 26, 2026 | Meltzer Jonathan C | EVP, Operations | Tax withholding(F) | 711 | $268.38 | $191K |
| Mar 26, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | Grant(A) | 1K | — | $0 |
| Mar 26, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | Tax withholding(F) | 382 | $268.38 | $103K |
| Mar 26, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | Grant(A) | 4K | — | $0 |
| Mar 26, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | Tax withholding(F) | 2K | $268.38 | $493K |
| Mar 26, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | Grant(A) | 6K | — | $0 |
| Mar 26, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | Tax withholding(F) | 3K | $268.38 | $731K |
| Mar 26, 2026 | Vaughn Bryan T | EVP, Diagnostics | Grant(A) | 2K | — | $0 |
| Mar 26, 2026 | Vaughn Bryan T | EVP, Diagnostics | Tax withholding(F) | 451 | $268.38 | $121K |
| Mar 26, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Tax withholding(F) | 755 | $268.38 | $203K |
| Mar 26, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Grant(A) | 2K | — | $0 |
| Mar 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Grant(A) | 9K | — | $0 |
| Mar 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Tax withholding(F) | 4K | $268.38 | $1.1M |
| Mar 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Grant(A) | 2K | — | $0 |
| Mar 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Tax withholding(F) | 863 | $268.38 | $232K |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Tax withholding(F) | 1K | $268.38 | $394K |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Grant(A) | 3K | — | $0 |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Tax withholding(F) | 5K | $268.38 | $1.2M |
| Mar 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Grant(A) | 9K | — | $0 |
| Mar 26, 2026 | Graham Anita Z | EVP, CHRO | Grant(A) | 7K | — | $0 |
| Mar 26, 2026 | Graham Anita Z | EVP, CHRO | Tax withholding(F) | 3K | $268.38 | $773K |
| Mar 26, 2026 | Schechter Adam H | President & CEO, Director | Tax withholding(F) | 26K | $268.38 | $7.0M |
| Mar 26, 2026 | Schechter Adam H | President & CEO, Director | Grant(A) | 58K | — | $0 |
| Mar 3, 2026 | Schechter Adam H | President & CEO, Director | Sell(S) | 9K | $279.96 | $2.4M |
| Feb 27, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | Sell(S) | 548 | $284.91 | $156K |
| Feb 24, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Sell(S) | 2K | $286.31 | $429K |
| Feb 19, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Sell(S) | 666 | $277.94 | $185K |
| Feb 12, 2026 | Meltzer Jonathan C | EVP, Operations | Sell(S) | 87 | $290.42 | $25K |
| Feb 11, 2026 | Anderson Kerrii B | Director | Option exercise(M) | 897 | — | — |
| Feb 11, 2026 | Anderson Kerrii B | Director | Option exercise(M) | 897 | — | $0 |
| Feb 11, 2026 | Davis Jeffrey A. | Director | Option exercise(M) | 897 | — | — |
| Feb 11, 2026 | Davis Jeffrey A. | Director | Option exercise(M) | 897 | — | $0 |
| Feb 11, 2026 | Kliphouse Kirsten Marie | Director | Option exercise(M) | 897 | — | — |
| Feb 11, 2026 | Kliphouse Kirsten Marie | Director | Option exercise(M) | 897 | — | $0 |
| Feb 11, 2026 | Kong Garheng | Director | Option exercise(M) | 897 | — | — |
| Feb 11, 2026 | Kong Garheng | Director | Option exercise(M) | 897 | — | $0 |
| Feb 11, 2026 | Neupert Peter M | Director | Option exercise(M) | 897 | — | — |
| Feb 11, 2026 | Neupert Peter M | Director | Option exercise(M) | 897 | — | $0 |
| Feb 11, 2026 | Parham Richelle P | Director | Option exercise(M) | 897 | — | — |
| Feb 11, 2026 | Parham Richelle P | Director | Option exercise(M) | 897 | — | $0 |
| Feb 11, 2026 | Wengel Kathryn E | Director | Option exercise(M) | 897 | — | — |
| Feb 11, 2026 | Wengel Kathryn E | Director | Option exercise(M) | 897 | — | $0 |
| Feb 11, 2026 | Rothman Paul | Director | Option exercise(M) | 897 | — | — |
| Feb 11, 2026 | Rothman Paul | Director | Option exercise(M) | 897 | — | $0 |
| Feb 11, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Option exercise(M) | 403 | — | — |
| Feb 11, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Tax withholding(F) | 138 | $289.89 | $40K |
| Feb 11, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Option exercise(M) | 403 | — | $0 |
| Feb 11, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Option exercise(M) | 740 | — | — |
| Feb 11, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Tax withholding(F) | 211 | $289.89 | $61K |
| Feb 11, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Option exercise(M) | 740 | — | $0 |
| Feb 11, 2026 | Graham Anita Z | EVP, CHRO | Option exercise(M) | 356 | — | — |
| Feb 11, 2026 | Graham Anita Z | EVP, CHRO | Tax withholding(F) | 109 | $289.89 | $32K |
| Feb 11, 2026 | Graham Anita Z | EVP, CHRO | Option exercise(M) | 356 | — | $0 |
| Feb 11, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Option exercise(M) | 216 | — | — |
| Feb 11, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Tax withholding(F) | 62 | $289.89 | $18K |
| Feb 11, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | Option exercise(M) | 216 | — | $0 |
| Feb 11, 2026 | Meltzer Jonathan C | EVP, Operations | Tax withholding(F) | 70 | $289.89 | $20K |
| Feb 11, 2026 | Meltzer Jonathan C | EVP, Operations | Option exercise(M) | 243 | — | — |
| Feb 11, 2026 | Meltzer Jonathan C | EVP, Operations | Option exercise(M) | 243 | — | $0 |
| Feb 11, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | Tax withholding(F) | 68 | $289.89 | $20K |
| Feb 11, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | Option exercise(M) | 230 | — | — |
| Feb 11, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | Option exercise(M) | 230 | — | $0 |
| Feb 11, 2026 | Schechter Adam H | President & CEO, Director | Option exercise(M) | 4K | — | — |
| Feb 11, 2026 | Schechter Adam H | President & CEO, Director | Tax withholding(F) | 2K | $289.89 | $441K |
| Feb 11, 2026 | Schechter Adam H | President & CEO, Director | Sell(S) | 5K | $284.38 | $1.5M |
| Feb 11, 2026 | Schechter Adam H | President & CEO, Director | Option exercise(M) | 4K | — | $0 |
| Feb 11, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Option exercise(M) | 806 | — | — |
| Feb 11, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Tax withholding(F) | 259 | $289.89 | $75K |
| Feb 11, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Option exercise(M) | 806 | — | $0 |
| Feb 11, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | Tax withholding(F) | 99 | $289.89 | $29K |
| Feb 11, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | Option exercise(M) | 376 | — | — |
| Feb 11, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | Option exercise(M) | 376 | — | $0 |
| Feb 11, 2026 | Vaughn Bryan T | EVP, Diagnostics | Option exercise(M) | 323 | — | — |
| Feb 11, 2026 | Vaughn Bryan T | EVP, Diagnostics | Tax withholding(F) | 93 | $289.89 | $27K |
| Feb 11, 2026 | Vaughn Bryan T | EVP, Diagnostics | Option exercise(M) | 323 | — | $0 |
| Feb 11, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | Option exercise(M) | 860 | — | — |
| Feb 11, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | Tax withholding(F) | 245 | $289.89 | $71K |
| Feb 11, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | Option exercise(M) | 860 | — | $0 |
| Feb 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Tax withholding(F) | 160 | $289.89 | $46K |
| Feb 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Option exercise(M) | 536 | — | — |
| Feb 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Tax withholding(F) | 46 | $289.89 | $13K |
| Feb 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Option exercise(M) | 160 | — | — |
| Feb 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Option exercise(M) | 160 | — | $0 |
| Feb 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | Option exercise(M) | 536 | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).